Unicycive Therapeutics, Inc. Common Stock (UNCY)

Typically moves ±9.21% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-11-12 ESTIMATED
search

Unicycive Therapeutics, Inc. Common Stock (UNCY) has a 19-report earnings history dating back to Aug 16, 2021. Its average absolute post-earnings move is ±9.21%, and 52.6% of those reactions were positive. Its largest post-earnings gain was +31.4% (Aug 14, 2024) and its largest decline was -47.53% (May 16, 2023). The next earnings report is predicted for 2026-11-12 (estimated).

Earnings reactions

How UNCY moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

19

Avg Abs. Movement

±9.21%

Positive %

52.6%

Negative %

47.4%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 12, 2026 ☀ PRE +7.98% open_in_new
May 12, 2026 ☀ PRE +2.39% open_in_new
Mar 30, 2026 ☀ PRE -4.69% open_in_new
Nov 12, 2025 ☀ PRE +7.6% open_in_new
event

Earnings Count

19

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.21%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 15 →
15
Funds holding
$12866641
Total value held
Buying
13 added · 2 reduced
Blackrock, Inc.
$6628757 +3836.67%
State Street Corp
$2111260 +462.51%
Citigroup Inc
$856647 +80011.40%
Northern Trust Corp
$853252 +406.25%
Goldman Sachs Group Inc
$681475 +436.32%

Frequently asked about UNCY earnings

When does Unicycive Therapeutics, Inc. Common Stock report earnings next? expand_more

Unicycive Therapeutics, Inc. Common Stock (UNCY)'s next earnings date is estimated for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does UNCY stock move after earnings? expand_more

Over 19 reports, UNCY has moved an average of ±9.21% the session after earnings, closing higher 52.6% of the time.

What was UNCY's biggest post-earnings move? expand_more

UNCY's largest post-earnings gain on record was +31.4% on Aug 14, 2024, and its largest decline was -47.53% on May 16, 2023.

Where can I find Unicycive Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Unicycive Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.